{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T00:18:17Z","timestamp":1719101897254},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,22]]},"DOI":"10.7759\/cureus.62923","type":"journal-article","created":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T18:43:53Z","timestamp":1719081833000},"source":"Crossref","is-referenced-by-count":0,"title":["Wide Spectrum of Flecainide Toxicity: A Case Report and Literature Review"],"prefix":"10.7759","author":[{"given":"Anton","family":"Stolear","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maxim","family":"Dulgher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju Young","family":"Bae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lila","family":"Kaminsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gini  P","family":"Jeyashanmugaraja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uzodinma","family":"Emerenini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2019.12.041","article-title":"Use of flecainide for the treatment of atrial fibrillation","volume":"125","author":"Echt DS","year":"2020","unstructured":"Echt DS, Ruskin JN. Use of flecainide for the treatment of atrial fibrillation. Am J Cardiol. 2020, 125:1123-33. 10.1016\/j.amjcard.2019.12.041","journal-title":"Am J Cardiol"},{"key":"ref2","unstructured":"Flecainide. Accessed. April 2, 2024: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Flecainide."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4330\/wjc.v7.i2.76","article-title":"Flecainide: current status and perspectives in arrhythmia management","volume":"7","author":"Andrikopoulos GK","year":"2015","unstructured":"Andrikopoulos GK, Pastromas S, Tzeis S. Flecainide: current status and perspectives in arrhythmia management. World J Cardiol. 2015, 7:76-85. 10.4330\/wjc.v7.i2.76","journal-title":"World J Cardiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198607033150106","article-title":"Flecainide","volume":"315","author":"Roden DM","year":"1986","unstructured":"Roden DM, Woosley RL. Flecainide. N Engl J Med. 1986, 315:36-41. 10.1056\/NEJM198607033150106","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13061781","article-title":"Catecholaminergic polymorphic ventricular tachycardia: clinical characteristics, diagnostic evaluation and therapeutic strategies","volume":"13","author":"Aggarwal A","year":"2024","unstructured":"Aggarwal A, Stolear A, Alam MM, Vardhan S, Dulgher M, Jang SJ, Zarich SW. Catecholaminergic polymorphic ventricular tachycardia: clinical characteristics, diagnostic evaluation and therapeutic strategies. J Clin Med. 2024, 13:1781. 10.3390\/jcm13061781","journal-title":"J Clin Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(81)90037-5","article-title":"Clinical electrophysiologic study of antiarrhythmic properties of flecainide: acute intraventricular delayed conduction and prolonged repolarization in regular paced and premature beats using intracardiac monophasic action potentials with programmed stimulation","volume":"102","author":"Olsson SB","year":"1981","unstructured":"Olsson SB, Edvardsson N. Clinical electrophysiologic study of antiarrhythmic properties of flecainide: acute intraventricular delayed conduction and prolonged repolarization in regular paced and premature beats using intracardiac monophasic action potentials with programmed stimulation. Am Heart J. 1981, 102:864-71. 10.1016\/0002-8703(81)90037-5","journal-title":"Am Heart J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(84)90499-5","article-title":"Electrophysiologic effects of flecainide acetate on sinus node function, anomalous atrioventricular connections, and pacemaker thresholds","volume":"53","author":"Hellestrand KJ","year":"1984","unstructured":"Hellestrand KJ, Nathan AW, Bexton RS, Camm AJ. Electrophysiologic effects of flecainide acetate on sinus node function, anomalous atrioventricular connections, and pacemaker thresholds. Am J Cardiol. 1984, 53:30-8. 10.1016\/0002-9149(84)90499-5","journal-title":"Am J Cardiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9149(98)00992-8","article-title":"Radiofrequency ablation of \"class IC atrial flutter\" in patients with resistant atrial fibrillation","volume":"83","author":"Nabar A","year":"1999","unstructured":"Nabar A, Rodriguez LM, Timmermans C, Smeets JL, Wellens HJ. Radiofrequency ablation of \"class IC atrial flutter\" in patients with resistant atrial fibrillation. Am J Cardiol. 1999, 83:785-7. 10.1016\/s0002-9149(98)00992-8","journal-title":"Am J Cardiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-117-2-141","article-title":"Proarrhythmia in patients treated for atrial fibrillation or flutter","volume":"117","author":"Falk RH","year":"1992","unstructured":"Falk RH. Proarrhythmia in patients treated for atrial fibrillation or flutter. Ann Intern Med. 1992, 117:141-50. 10.7326\/0003-4819-117-2-141","journal-title":"Ann Intern Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(85)90413-2","article-title":"Hemodynamic effects of intravenous flecainide relative to the level of ventricular function in patients with coronary artery disease","volume":"109","author":"Josephson MA","year":"1985","unstructured":"Josephson MA, Kaul S, Hopkins J, Kvam D, Singh BN. Hemodynamic effects of intravenous flecainide relative to the level of ventricular function in patients with coronary artery disease. Am Heart J. 1985, 109:41-5. 10.1016\/0002-8703(85)90413-2","journal-title":"Am Heart J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3109\/15563659009038586","article-title":"Clinical course and outcome in class IC antiarrhythmic overdose","volume":"28","author":"K\u00f6ppel C","year":"1990","unstructured":"K\u00f6ppel C, Oberdisse U, Heinemeyer G. Clinical course and outcome in class IC antiarrhythmic overdose. J Toxicol Clin Toxicol. 1990, 28:433-44. 10.3109\/15563659009038586","journal-title":"J Toxicol Clin Toxicol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.62.723.61","article-title":"Dysarthria and visual hallucinations due to flecainide toxicity","volume":"62","author":"Ramhamadany E","year":"1986","unstructured":"Ramhamadany E, Mackenzie S, Ramsdale DR. Dysarthria and visual hallucinations due to flecainide toxicity. Postgrad Med J. 1986, 62:61-2. 10.1136\/pgmj.62.723.61","journal-title":"Postgrad Med J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2020.04.052","article-title":"The case of flecainide toxicity: what to look for and how to treat","volume":"59","author":"Newson JM","year":"2020","unstructured":"Newson JM, Santos CD, Walters BL, Todd BR. The case of flecainide toxicity: what to look for and how to treat. J Emerg Med. 2020, 59:e43-7. 10.1016\/j.jemermed.2020.04.052","journal-title":"J Emerg Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/BF00717997","article-title":"Hemofiltration clearance of flecainide in a patient with acute renal failure","volume":"14","author":"Borgeat A","year":"1988","unstructured":"Borgeat A, Biollaz J, Freymond B, Bayer-Berger M, Chiolero R. Hemofiltration clearance of flecainide in a patient with acute renal failure. Intensive Care Med. 1988, 14:236-7. 10.1007\/BF00717997","journal-title":"Intensive Care Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s12012-016-9380-0","article-title":"Flecainide toxicity: a case report and systematic review of its electrocardiographic patterns and management","volume":"17","author":"Valentino MA","year":"2017","unstructured":"Valentino MA, Panakos A, Ragupathi L, Williams J, Pavri BB. Flecainide toxicity: a case report and systematic review of its electrocardiographic patterns and management. Cardiovasc Toxicol. 2017, 17:260-6. 10.1007\/s12012-016-9380-0","journal-title":"Cardiovasc Toxicol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/263620-wide-spectrum-of-flecainide-toxicity-a-case-report-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T18:43:59Z","timestamp":1719081839000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/263620-wide-spectrum-of-flecainide-toxicity-a-case-report-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,22]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.62923","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,22]]}}}